DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, will host an investor and analyst day on Friday, December 9, 2011 from 2:00 to 4:30 p.m. at the New York Palace in New York City.
The agenda will include physician presentations, which will discuss the new data from PROTECT II and new product updates. The meeting will also include an overview with Michael R. Minogue, Chairman, President and Chief Executive Officer of Abiomed, including details on recent quarterly financials and company developments.
